Giuseppe Penna spent over 18 years of his career in a pharmaceutical environment supporting the advancement of a broad pipeline of products in several disease indications. In 2010 G. Penna joined Prof. Rescigno’s team, contributing to the establishment of industrial-academy interaction platform and translational exploitation of internal scientific projects. His scientific interest is in the field of immunoregulatory mechanisms applied to the treatment of multiple mucosal inflammatory morbidities and cancer immunotherapy.